Skip to main content

Want a detailed portfolio tracker?

Insmed (INSM) P/E (2011 - 2026)

Insmed (INSM) P/E from Jun 30, 2011 to Jul 21, 2026. The TTM Insmed (INSM) P/E is -19.56. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Insmed (INSM)

YearP/EChange
2026-19.56-30.23%
2025-28.03+119.57%
2024-12.77+113.31%
2023-5.99+8.44%
2022-5.52-22.81%
2021-7.15-36.24%
2020-11.22+39.56%
2019-8.04+157.83%
2018-3.12-69.89%
2017-10.35+75.97%
2016-5.88-34.62%
2015-9.00+4.31%
2014-8.63-20.47%
2013-10.85+136.14%
2012-4.59+170.55%
2011-1.70N/A

Comparison Insmed (INSM) P/E with competitors

Insmed (INSM) P/E is -19.56.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.38%
FGENFibroGen Inc0.24-101.23%
CHRSCoherus Biosciences Inc0.85-104.34%
FBIOFortress Biotech Inc0.95-104.85%
ORMPOramed Pharmaceuticals Inc1.50-107.68%
AGENAgenus Inc3.01-115.39%
INVAInnoviva Inc3.15-116.12%
VXRTVaxart Inc3.55-118.15%
CRMDCorMedix Inc3.63-118.55%
CVACCureVac N.V.4.45-122.73%
GLPGGalapagos NV4.86-124.84%
SRPTSarepta Therapeutics Inc4.88-124.96%
ABEOAbeona Therapeutics Inc5.39-127.54%
ABUSArbutus Biopharma Corp5.60-128.60%
ZVRAZevra Therapeutics Inc5.89-130.10%
SPROSpero Therapeutics Inc6.23-131.84%
CGENCompugen Ltd6.31-132.28%
RIGLRigel Pharmaceuticals6.87-135.13%
SLXNSilexion Therapeutics Corp7.30-137.30%
OMEROmeros Corporation9.26-147.33%
AUPHAurinia Pharmaceuticals Inc9.58-149.00%
PLXProtalix BioTherapeutics Inc10.89-155.68%
ACADAcadia Pharmaceuticals Inc11.73-159.96%
TBPHTheravance Biopharma Inc12.26-162.68%
ADMAAdma Biologics Inc12.42-163.48%
HRMYHarmony Biosciences Holdings Inc13.82-170.65%
SABSSAB Biotherapeutics Inc14.14-172.26%
NAGENiagen Bioscience Inc14.82-175.75%
INCYIncyte Corp15.82-180.89%
REGNRegeneron Pharmaceuticals Inc15.86-181.06%
PBYIPuma Biotechnology Inc17.32-188.52%
CPRXCatalyst Pharmaceuticals Inc17.44-189.15%
EXELExelixis Inc17.54-189.66%
TGTXTG Therapeutics Inc18.97-196.96%
MDXGMimedx Group Inc20.55-205.07%
XOMAXOMA Royalty Corp22.87-216.94%
ARGXArgen X SE24.30-224.22%
CTMXCytomX Therapeutics Inc24.82-226.89%
XOMAOXOMA Royalty Corp25.34-229.57%
HALOHalozyme Therapeutics Inc25.62-230.99%
XOMAPXOMA Royalty Corp25.67-231.23%
VRTXVertex Pharmaceuticals Inc27.99-243.11%
RPRXRoyalty Pharma plc - Class A28.69-246.66%
SLNOSoleno Therapeutics Inc29.02-248.33%
ASNDAscendis Pharma A/S30.09-253.80%
LGNDLigand Pharmaceuticals Inc - Class B37.91-293.81%
APLSApellis Pharmaceuticals Inc39.02-299.48%
BMRNBiomarin Pharmaceutical Inc42.21-315.79%
KRYSKrystal Biotech Inc45.34-331.80%
ONCBeiGene Ltd69.54-455.50%
PHARPharming Group N.V.75.03-483.55%
TECHBio-Techne Corp101.96-621.23%
VCELVericel Corp109.92-661.94%
ALNYAlnylam Pharmaceuticals Inc117.96-703.06%
GMABGenmab140.29-817.19%
TLXTelix Pharmaceuticals Ltd162.15-928.96%
CORTCorcept Therapeutics Inc212.86-1188.17%